Maryland 2026 Session Status: Introduced 1 D cosponsors

HB1380 — Health Insurance - Prescriptions for Gender-Affirming Care and Hormone Therapy - Coverage and Dispensing Requirements

Last action — Hearing (Primary, House of Origin)

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; and altering the amount of certain prescription drugs that a pharmacist is allowed to dispense on or after January 1, 2027.

Bill Text

We don't have the full text on file for this bill yet.

Read HB1380 on the official Maryland source →

Action History

  1. Hearing (Primary, House of Origin)

  2. First Reading (House of Origin)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 187 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (187)

187 members have not signed on to this bill.

Show all 187 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB1380 do?
Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; and altering the amount of certain prescription drugs that a pharmacist is allowed to dispense on or after January 1, 2027.
Who sponsors HB1380?
HB1380 is sponsored by Delegate Kris Fair (Democrat).
What is the current status of HB1380?
This bill has been introduced in the House of Delegates. Introduced February 13, 2026. It must pass committee before a floor vote.
Where can I track HB1380?
Track HB1380 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB1380

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB1380

Last checked for changes about 2 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →